Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy

BACKGROUND: Acute kidney injury (AKI) occurs frequently in hospitalized patients and has been associated with the administration of certain medications. Concerns have been raised in recent reports that the antibiotic combination of vancomycin and piperacillin/tazobactam (combV/P) may be more associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tiffany, Kandiah, Sheetal, Patel, Manish, Rab, Saira, Wong, Jordan, Xue, Wenqiong, Easley, Kirk, Anderson, Albert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609063/
https://www.ncbi.nlm.nih.gov/pubmed/26476979
http://dx.doi.org/10.1186/s13104-015-1518-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609063/
https://www.ncbi.nlm.nih.gov/pubmed/26476979
http://dx.doi.org/10.1186/s13104-015-1518-9

Ejemplares similares